Investment Career Paths for Scientists

One year after graduating with a degree in political science, Jim Reddoch caught the molecular biology bug and entered the graduate program at the University of Alabama at Birmingham (UAB). Two years into that program, he already had misgivings. Advisers suggested that, once he had a Ph.D., he was virtually assured of an immediate career in academic research. Watching his fellow graduate students finish degrees and search for jobs, "I found that was not the case at all," he recalls. Here's a

Written byJames Kling
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

One year after graduating with a degree in political science, Jim Reddoch caught the molecular biology bug and entered the graduate program at the University of Alabama at Birmingham (UAB). Two years into that program, he already had misgivings. Advisers suggested that, once he had a Ph.D., he was virtually assured of an immediate career in academic research. Watching his fellow graduate students finish degrees and search for jobs, "I found that was not the case at all," he recalls.

Here's a partial list of jobs related to biotech, pharmaceutical, or healthcare investing: Senior analyst/research associate: Perhaps the path of least resistance to those who have no formal business training (although a class or two in finance would be a good idea). The research associate reports to a more experienced senior analyst. Track a limited number of companies, and produce periodic reports with a recommendation to buy, hold, or sell. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies